Insider · CIK 0001696864
Martin J. Madden
Files at MBOT (Microbot Medical Inc.), NVCR (NovoCure Ltd). First filing Jun 4, 2025, latest Jun 4, 2025.
Martin J. Madden files SEC Form 4 as director at NVCR (NovoCure Ltd), and also at MBOT (Microbot Medical Inc.). Since Jun 4, 2025, Martin J. Madden has reported 0 open-market buys worth $0 and 1 open-market sell worth $17k, the latest filed on Jun 4, 2025.
A track record needs three past buys with six months of prices behind them; Martin J. Madden has 0, so none is measured yet.
The newest scored trade: sold $17k of NVCR on Jun 3, 2025, filed Jun 4, 2025, scored 30 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NVCR: NovoCure Ltd
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | NovoCure Ltd | $17k 999 shares | -5% | +17% from low-49% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +11,610 | $0.00 | $0 | 30,284 | Jun 5, 2026 |
| Jun 3, 2026 | NVCR NovoCure Ltd | AGrant or award Stock Option (Right to Buy)derivative | +16,999 | $0.00 | $0 | 16,999 | Jun 5, 2026 |
| Apr 1, 2026 | MBOT Microbot Medical Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Apr 3, 2026 |
| Jun 4, 2025 | NVCR NovoCure Ltd | AGrant or award Stock Option (Right to Buy)derivative | +33,393 | $0.00 | $0 | 33,393 | Jun 6, 2025 |
| Jun 3, 2025 | NVCR NovoCure Ltd | SOpen-market sale Ordinary Shares | -999 | $17.19 | $17k | 18,674 | Jun 4, 2025 |
Questions about Martin J. Madden
Answered from the filings on this page, as of the latest one.
Is Martin J. Madden buying or selling?
Not in the last 12 months. Martin J. Madden's latest open-market trade on SEC Form 4 was sold $17k of NVCR on Jun 3, 2025.
How did Martin J. Madden's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Martin J. Madden has 0.
Where does Martin J. Madden file Form 4?
Martin J. Madden has filed Form 4 at NVCR (NovoCure Ltd); MBOT (Microbot Medical Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.